Derek Archila Analyst Performance

Managing Director, Biotechnology Equity Research at Wells Fargo & Company

Derek Archila is a stock analyst at Wells Fargo & Company in the healthcare sector, covering 52 publicly traded companies. Over the past year, Derek Archila has issued 93 stock ratings, including buy and hold recommendations. While full access to Derek Archila's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Derek Archila's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access to unlock analyst rankings MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 291 Last 9 Years
Buy Recommendations: 66.55% 193 Buy Ratings
Companies Covered: 52 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.7%	2 ratings
Buy	65.9%	191 ratings
Hold	33.4%	97 ratings
Sell	0.0%	0 ratings

Out of 290 total stock ratings issued by Derek Archila at Wells Fargo & Company, the majority (65.9%) have been Buy recommendations, followed by 33.4% Hold and 0.7% Strong Buy.

Best & Worst Calls

Best Call
0000.0%
ALMS
Jul 2025
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
QTTB
Sep 2024
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	96.2% of companies on NASDAQ	50 companies
NYSE	3.8% of companies on NYSE	2 companies

Derek Archila, an analyst at Wells Fargo & Company, currently covers 52 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Healthcare 52 companies	100.0%

Derek Archila of Wells Fargo & Company specializes in stock coverage within the Healthcare sector.

Coverage Industries

Industry	Percentage
BIOTECHNOLOGY 40 companies	76.9%
PHARMACEUTICALS 12 companies	23.1%

About Derek Archila

Senior Equity Research Analyst specializing in small- and mid-cap biotechnology companies, with a primary focus on immunology & inflammation (I&I), targeted oncology, and rare diseases. I am a key contributor to the #4 ranked Wells Fargo SMID-cap biotech franchise, and was individually recognized as a “Runner-Up” in the Institutional Investor (Extel) poll for Biotechnology Small & Mid-Cap Equity Research in both 2023 and 2024, ranking among the top 5 analysts in 2024.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

0 Results

Export

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
ASND Ascendis Pharma A/S	11/13/2026	Boost Price Target	$275.18	$330.00	Overweight
ALMS Alumis	11/13/2026	Lower Price Target	$5.59	$18.00	Overweight
IMVT Immunovant	11/10/2026	Boost Price Target	$35.77	$47.00	Overweight
ATYR aTyr Pharma	11/6/2026	Boost Price Target	$6.08	$4.00	Equal Weight
GLUE Monte Rosa Therapeutics	11/6/2026	Lower Price Target	$10.09	$25.00	Overweight
VRDN Viridian Therapeutics	11/5/2026	Boost Price Target	$29.45	$34.00	Overweight
NRIX Nurix Therapeutics	11/4/2026	Lower Price Target	$15.22	$20.00	Overweight
SEPN Septerna	11/4/2026	Boost Price Target	$46.50	$61.00	Overweight
INCY Incyte	10/30/2026	Lower Price Target	$121.12	$127.00	Equal Weight
ALNY Alnylam Pharmaceuticals	10/30/2026	Lower Price Target	$170.41	$220.00	Equal Weight
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
XNCR Xencor	10/27/2026	Boost Price Target	$29.18	$44.00	Overweight
ARGX argenex	10/23/2026	Lower Price Target	$868.33	$1,336.00	Overweight
IRON Disc Medicine	10/20/2026	Boost Price Target	$78.93	$124.00	Overweight
ARGX argenex	10/14/2026	Boost Price Target	$829.01	$1,356.00	Overweight
ALNY Alnylam Pharmaceuticals	10/14/2026	Lower Price Target	$225.16	$253.00	Equal Weight
TRAX First Tracks Biotherapeutics	10/12/2026	Boost Price Target	$34.05	$70.00	Overweight
TRAX First Tracks Biotherapeutics	10/9/2026	Boost Price Target	$32.01	$62.00	Overweight
INCY Incyte	10/1/2026	Boost Price Target	$121.35	$128.00	Equal Weight
IRON Disc Medicine	9/16/2026	Boost Price Target	$67.30	$86.00	Overweight
PYXS Pyxis Oncology	9/9/2026	Boost Price Target	$3.86	$19.00	Overweight
ALMS Alumis	9/2/2026	Lower Price Target	$9.47	$25.00	Overweight
ALMS Alumis	9/1/2026	Lower Price Target	$9.47	$25.00	Overweight
KYMR Kymera Therapeutics	8/27/2026	Boost Price Target	$123.83	$151.00	Overweight
ARGX argenex	8/26/2026	Boost Price Target	$1,019.49	$1,415.00	Overweight
ALNY Alnylam Pharmaceuticals	8/14/2026	Lower Price Target	$223.21	$256.00	Equal Weight
CABA Cabaletta Bio	8/14/2026	Lower Price Target	$2.67	$3.00	Equal Weight
SEPN Septerna	8/12/2026	Boost Price Target	$47.76	$50.00	Overweight
BBIO BridgeBio Pharma	8/11/2026	Boost Price Target	$84.67	$102.00	Overweight
GLUE Monte Rosa Therapeutics	8/7/2026	Lower Price Target	$15.87	$27.00	Overweight
ARVN Arvinas	8/4/2026	Downgrade	$9.01	$11.00	Equal Weight
PYXS Pyxis Oncology	8/3/2026	Initiated Coverage	$2.65	$12.00	Overweight
PYXS Pyxis Oncology	8/3/2026	Initiated Coverage	$3.04	$12.00	Overweight
ALNY Alnylam Pharmaceuticals	7/31/2026	Lower Price Target	$204.09	$316.00	Equal Weight
CLDX Celldex Therapeutics	7/29/2026	Boost Price Target	$35.91	$72.00	Overweight
TRAX First Tracks Biotherapeutics	7/28/2026	Boost Price Target	$42.03	$55.00	Overweight
CLDX Celldex Therapeutics	7/22/2026	Lower Price Target	$34.59	$48.00	Overweight
XFOR X4 Pharmaceuticals	7/10/2026	Initiated Coverage	$3.96	$11.00	Overweight
XFOR X4 Pharmaceuticals	7/10/2026	Initiated Coverage	$4.41	$11.00	Overweight
VRDN Viridian Therapeutics	6/29/2026	Upgrade	$19.00	$31.00	Overweight
RYTM Rhythm Pharmaceuticals	6/15/2026	Boost Price Target	$88.38	$155.00	Overweight
Every Starlink dish pays this stock (Ad) There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit. Claim your free stock pick before December 8th
TRAX First Tracks Biotherapeutics	6/8/2026	Initiated Coverage	$16.60	$30.00	Overweight
NRIX Nurix Therapeutics	6/8/2026	Downgrade	$15.59	$25.00	Hold
TRAX First Tracks Biotherapeutics	6/8/2026	Initiated Coverage	$15.75	$30.00	Overweight
ARGX argenex	6/1/2026	Boost Price Target	$829.09	$1,291.00	Overweight
ALMS Alumis	5/15/2026	Boost Price Target	$24.63	$51.00	Overweight
CABA Cabaletta Bio	5/15/2026	Boost Price Target	$3.51	$4.00	Equal Weight
CLDX Celldex Therapeutics	5/13/2026	Boost Price Target	$32.10	$54.00	Overweight
ASND Ascendis Pharma A/S	5/8/2026	Lower Price Target	$246.14	$326.00	Overweight
ARGX argenex	5/8/2026	Boost Price Target	$787.31	$1,260.00	Overweight
RYTM Rhythm Pharmaceuticals	5/6/2026	Boost Price Target	$93.83	$144.00	Overweight
ALNY Alnylam Pharmaceuticals	5/1/2026	Boost Price Target	$305.35	$377.00	Equal Weight
SLNO Soleno Therapeutics	4/17/2026	Set Price Target	$52.57	$53.00	Equal Weight
APLS Apellis Pharmaceuticals	4/17/2026	Downgrade	$40.87	$41.00	Equal Weight
SLNO Soleno Therapeutics	4/17/2026	Downgrade	$52.78	$53.00	Equal Weight
NRIX Nurix Therapeutics	4/9/2026	Lower Price Target	$15.80	$28.00	Overweight
VRDN Viridian Therapeutics	3/31/2026	Lower Price Target	$18.82	$20.00	Equal Weight
ALXO ALX Oncology	3/19/2026	Initiated Coverage	$2.15	$5.00	Overweight
GLUE Monte Rosa Therapeutics	3/18/2026	Lower Price Target	$16.03	$29.00	Overweight
RYTM Rhythm Pharmaceuticals	3/12/2026	Boost Price Target	$90.02	$143.00	Overweight
SEPN Septerna	3/3/2026	Boost Price Target	$27.47	$48.00	Overweight
IRON Disc Medicine	3/2/2026	Boost Price Target	$65.48	$79.00	Overweight
ARGX argenex	2/27/2026	Lower Price Target	$775.04	$1,247.00	Overweight
SLNO Soleno Therapeutics	2/27/2026	Lower Price Target	$38.88	$110.00	Overweight
RYTM Rhythm Pharmaceuticals	2/27/2026	Lower Price Target	$93.22	$136.00	Overweight
IRON Disc Medicine	2/17/2026	Lower Price Target	$55.99	$78.00	Overweight
BBIO BridgeBio Pharma	2/13/2026	Boost Price Target	$74.58	$98.00	Overweight
INCY Incyte	2/11/2026	Lower Price Target	$98.44	$101.00	Equal Weight
VRDN Viridian Therapeutics	2/3/2026	Boost Price Target	$33.20	$29.00	Equal Weight
NRIX Nurix Therapeutics	1/29/2026	Lower Price Target	$17.87	$29.00	Overweight
SLNO Soleno Therapeutics	1/20/2026	Reiterated Rating	$42.48	$114.00	Overweight
RYTM Rhythm Pharmaceuticals	1/20/2026	Boost Price Target	$101.63	$145.00	Overweight
ASND Ascendis Pharma A/S	1/20/2026	Boost Price Target	$205.83	$330.00	Overweight
INCY Incyte	1/20/2026	Reiterated Rating	$106.21	$107.00	Equal Weight
BBIO BridgeBio Pharma	1/20/2026	Boost Price Target	$76.86	$88.00	Overweight
APLS Apellis Pharmaceuticals	1/20/2026	Lower Price Target	$19.97	$26.00	Overweight
ALNY Alnylam Pharmaceuticals	1/20/2026	Lower Price Target	$348.61	$376.00	Equal Weight
ARGX argenex	1/20/2026	Boost Price Target	$798.13	$1,317.00	Overweight
INCY Incyte	1/20/2026	Downgrade	$102.62	$107.00	Equal Weight
ASND Ascendis Pharma A/S	1/9/2026	Boost Price Target	$208.75	$322.00	Overweight
VTYX Ventyx Biosciences	1/8/2026	Reiterated Rating	$13.79	$14.00	Equal Weight
GLUE Monte Rosa Therapeutics	1/8/2026	Boost Price Target	$25.37	$30.00	Overweight
VTYX Ventyx Biosciences	1/7/2026	Downgrade	$13.81		Hold
ALMS Alumis	1/6/2026	Boost Price Target	$17.19	$39.00	Overweight
KYTX Kyverna Therapeutics	12/16/2025	Boost Price Target	$10.82	$33.00	Overweight
NRIX Nurix Therapeutics	12/16/2025	Boost Price Target	$18.89	$30.00	Overweight
IRON Disc Medicine	12/16/2025	Boost Price Target	$91.06	$109.00	Overweight
ARGX argenex	12/11/2025	Boost Price Target	$886.15	$1,316.00	Overweight
KYMR Kymera Therapeutics	12/9/2025	Boost Price Target	$94.30	$116.00	Overweight
ORIC Oric Pharmaceuticals	12/8/2025	Boost Price Target	$11.00	$25.00	Overweight
INCY Incyte	12/8/2025	Boost Price Target	$102.52	$116.00	Overweight
Top Trader Reveals Stunning Black Friday Deal (Ad) Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders. Get the Snapback Indicator for just $7 in the Black Friday sale today.
ANNX Annexon	11/19/2025	Boost Price Target	$3.20	$27.00	Overweight
SEPN Septerna	11/14/2025	Upgrade	$19.24	$28.00	Overweight
ORIC Oric Pharmaceuticals	11/14/2025	Lower Price Target	$12.84	$19.00	Overweight
BBIO BridgeBio Pharma	11/11/2025	Boost Price Target	$63.20	$84.00	Overweight
ALNY Alnylam Pharmaceuticals	11/11/2025	Boost Price Target	$444.86	$479.00	Equal Weight
GLUE Monte Rosa Therapeutics	11/7/2025	Boost Price Target	$12.24	$13.00	Equal Weight
VTYX Ventyx Biosciences	11/7/2025	Boost Price Target	$8.60	$14.00	Overweight
ARVN Arvinas	11/6/2025	Lower Price Target	$9.81	$15.00	Overweight
SLNO Soleno Therapeutics	11/5/2025	Reiterated Rating	$63.85	$106.00	Overweight
KYMR Kymera Therapeutics	11/5/2025	Boost Price Target	$58.82	$69.00	Overweight
ANAB AnaptysBio	11/5/2025	Boost Price Target	$36.13	$81.00	Overweight
KYTX Kyverna Therapeutics	10/29/2025	Boost Price Target	$7.82	$31.00	Overweight
INCY Incyte	10/29/2025	Boost Price Target	$88.61	$97.00	Overweight
NRIX Nurix Therapeutics	10/23/2025	Lower Price Target	$10.60	$21.00	Overweight
EXEL Exelixis	10/21/2025	Lower Price Target	$34.54	$30.00	Equal Weight
KZR Kezar Life Sciences	10/17/2025	Set Price Target	$4.17	$5.00	Equal Weight
APLS Apellis Pharmaceuticals	10/15/2025	Initiated Coverage	$23.15	$32.00	Overweight
KYTX Kyverna Therapeutics	10/8/2025	Boost Price Target	$5.41	$27.00	Overweight
CCCC C4 Therapeutics	9/23/2025	Boost Price Target	$2.61	$10.00	Overweight
ATYR aTyr Pharma	9/15/2025	Reiterated Rating	$1.05		Equal Weight
SLNO Soleno Therapeutics	8/20/2025	Initiated Coverage	$66.81	$123.00	Overweight
CLDX Celldex Therapeutics	8/20/2025	Lower Price Target	$21.24	$38.00	Overweight
STRO Sutro Biopharma	8/12/2025	Lower Price Target	$7.73	$30.00	Equal Weight
ASND Ascendis Pharma A/S	8/8/2025	Reiterated Rating	$190.35	$295.00	Overweight
ZNTL Zentalis Pharmaceuticals	8/7/2025	Lower Price Target	$1.43	$5.00	Equal Weight
VRDN Viridian Therapeutics	8/7/2025	Lower Price Target	$16.71	$26.00	Equal Weight
ARVN Arvinas	8/7/2025	Lower Price Target	$6.14	$16.00	Overweight
INCY Incyte	8/6/2025	Upgrade	$77.72	$89.00	Overweight
ARGX argenex	7/31/2025	Boost Price Target	$670.33	$756.00	Overweight
INCY Incyte	7/30/2025	Boost Price Target	$77.88	$67.00	Equal Weight
ALMS Alumis	7/25/2025	Initiated Coverage	$4.05	$17.00	Overweight
RYTM Rhythm Pharmaceuticals	7/10/2025	Boost Price Target	$89.53	$129.00	Overweight
KYMR Kymera Therapeutics	6/26/2025	Lower Price Target	$44.98	$53.00	Overweight
ATYR aTyr Pharma	6/20/2025	Boost Price Target	$206.80	$1,000.00	Overweight
APLS Apellis Pharmaceuticals	6/2/2025	Boost Price Target	$19.21	$29.00	Equal Weight
SEPN Septerna	5/16/2025	Boost Price Target	$10.48	$18.00	Equal Weight
APLS Apellis Pharmaceuticals	5/8/2025	Lower Price Target	$17.90	$26.00	Equal Weight
ARVN Arvinas	5/2/2025	Lower Price Target	$7.78	$19.00	Overweight
INCY Incyte	4/30/2025	Boost Price Target	$61.16	$59.00	Equal Weight
EXEL Exelixis	4/17/2025	Reiterated Rating	$36.19		Market Outperform
NRIX Nurix Therapeutics	4/9/2025	Lower Price Target	$9.86	$25.00	Overweight
RYTM Rhythm Pharmaceuticals	4/7/2025	Boost Price Target	$54.94	$91.00	Overweight
CABA Cabaletta Bio	4/1/2025	Lower Price Target	$1.27	$3.00	Equal Weight
SEPN Septerna	3/28/2025	Lower Price Target	$6.22	$11.00	Equal Weight
GLUE Monte Rosa Therapeutics	3/21/2025	Lower Price Target	$5.72	$10.00	Equal Weight
ARVN Arvinas	3/12/2025	Set Price Target	$8.51	$26.00	Overweight
QTTB Q32 Bio	3/12/2025	Lower Price Target	$1.87	$15.00	Equal Weight
ARGX argenex	2/28/2025	Boost Price Target	$619.04	$741.00	Overweight
EXEL Exelixis	2/24/2025	Downgrade	$36.85	$36.00	Equal Weight
SEPN Septerna	2/18/2025	Downgrade	$12.96	$14.00	Equal Weight
Every Starlink dish pays this stock (Ad) There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit. Claim your free stock pick before December 8th
ANAB AnaptysBio	2/13/2025	Boost Price Target	$19.29	$51.00	Overweight
ZNTL Zentalis Pharmaceuticals	1/30/2025	Lower Price Target	$1.66	$6.00	Equal Weight
CCCC C4 Therapeutics	12/19/2024	Upgrade	$3.65	$12.00	Overweight
CABA Cabaletta Bio	12/19/2024	Downgrade	$2.29	$6.00	Equal Weight
GLUE Monte Rosa Therapeutics	12/19/2024	Downgrade	$7.03	$11.00	Equal Weight
VRDN Viridian Therapeutics	12/19/2024	Reiterated Rating	$18.93	$27.00	Equal Weight
ZYME Zymeworks	12/19/2024	Boost Price Target	$12.80	$14.00	Equal Weight
QTTB Q32 Bio	12/11/2024	Reiterated Rating	$24.41	$16.00	Equal Weight
SLRN Acelyrin	12/11/2024	Lower Price Target	$3.32	$13.00	Overweight
KYMR Kymera Therapeutics	12/2/2024	Upgrade	$46.85	$57.00	Overweight
SEPN Septerna	11/19/2024	Initiated Coverage	$23.55	$43.00	Overweight

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Derek Archila Analyst Performance

Ratings Distribution

Best & Worst Calls

Exchange Coverage

Coverage Focus

Coverage Industries

About Derek Archila

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Derek Archila Analyst Performance

Analyst Rankings, Coverage, and Performance Statistics

Ratings Distribution

Best & Worst Calls

Exchange Coverage

Coverage Focus

Coverage Industries

About Derek Archila

Derek Archila's Ratings History at Wells Fargo & Company

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools